Insurance risk is the risk that future insurance claims and benefits cannot be covered by premium and / or investment income, or that insurance liabilities are not sufficient, because future expenses, claims and benefits differ from the assumptions used in determining the best estimate liability. Insurance risk manifests itself in both the Non-life and the Life portfolio. The Non-life portfolio covers the property and casualty, disability and healthcare sectors. The Life portfolio consists of funeral, individual life and pensions business.
Risk-mitigating measures are used to reduce and contain the volatility of results or to decrease the possible negative impact on value as an alternative for the capital requirement. Proper pricing, underwriting, reinsurance, claims management, and diversification are the main risk mitigating actions for insurance risks. By offering a range of different insurance products, with various product benefits and contract lengths, and across Life, Disability and Health and P&C insurance risk, a.s.r. reduces the likelihood that a single risk event will have a material impact on a.s.r.’s financial condition.
The solvency buffer is held by a.s.r. to cover the risk that claims may exceed the available insurance provisions and to ensure its solidity. The solvency position of a.s.r. is determined and continuously monitored in order to assess if a.s.r. meets the regulatory requirements.
Aegon Levensverzekering (Aegon life) and Aegon Spaarkas (Aegon spaarkas) use a Partial Internal Model (PIM) to calculate the solvency position. The PIM contains Internal Models for (i) mortality risk and (ii) longevity risk. For the other risks, the Solvency II standard formula is applied.
ASR Levensverzekeringen (a.s.r. life), ASR Schadeverzekeringen (a.s.r. non-life) and ASR Ziektekostenverzekeringen (a.s.r. health) use the Solvency II standard formula (SF) to calculate the solvency position.
The Solvency Capital Requirement (SCR) for each insurance risk is determined as the change in own funds caused by a predetermined shock which is calibrated to a 1-in-200-year event. The basis for these calculations are the Solvency II technical provisions which are calculated as the sum of a best estimate and a risk margin.
The insurance risk arising from the insurance portfolios of a.s.r. is as follows:
| 31 December 2023 | 31 December 2022 | ||
---|---|---|---|---|
(in € million) | SF | IM | SF | IM |
Life insurance risk | 1,807 | 1,013 | 1,313 | - |
Health insurance risk | 1,508 | - | 1,243 | - |
Non-life insurance risk | 706 | - | 609 | 0 |
Total excluding diversification between insurance risks | 4,021 | 1,013 | 3,166 | 0 |
| | | | |
The Life insurance risk increased meanly as a result of the integration of Aegon life. Next to that the change of the SCR was the result of decreased interest rates and model changes, which largely counteracted each other.
The Health and Non life insurance risk increased as a result of update of the integration of Aegon and the growth of the insured population.
Solvency II sensitivities
a.s.r. has assessed the impact of various sensitivities on the solvency ratio. The sensitivities as at 31 December 2023 and 2022, expressed as impact on the group solvency ratio (in percentage points) are as follows:
Effect on: | Available capital | Required capital | Ratio | |||
---|---|---|---|---|---|---|
Type of risk (%-points) | 31 December 2023 | 31 December 2022 | 31 December 2023 | 31 December 2022 | 31 December 2023 | 31 December 2022 |
Expenses +10% | -6 | -6 | -1 | -2 | -7 | -8 |
Mortality rates, all products -5% | -5 | -3 | - | -1 | -5 | -4 |
Lapse rates -10% | - | - | - | -1 | - | - |
Risk | Scenario |
---|---|
Expense risk | Measured as the impact of a 10% increase in expense levels. |
Mortality risk | Measured as the impact of a 5% decrease in all mortality rates. |
Lapse risk | Measured as the risk of a 10% decrease in lapse rates. |
The table above shows that the SCR sensitivities in 2023 are (almost) similar to the sensitivities of 2022. The impact on the ratio is the opposite if a reversed scenario is taken into account.
7.8.2.1 Life Insurance risk
The Life portfolio can be divided into Funeral, Individual life and Pensions. The insurance contracts are sold primarily to retail and wholesale clients through intermediaries.
The products are sold as insurance products in cash or unit-linked contracts. With respect to products in cash, the investment risk is fully borne by the insurer whereas, in the case of unit-linked products, the majority of the investment risk is for the policyholder’s account.
The solvency capital requirement (SCR) for Life insurance risks is determined per policy for the Funeral and Life portfolio and per participant for the Pension portfolio. All shocks are applied to each policy/participant and a SCR value is only determined if applying the shock leads to a higher best estimate.
The following Life insurance risks are involved:
Mortality risk
Mortality risk is associated with (re)insurance obligations, such as endowment or term assurance policies, where a payment or payments are made in case of the policyholder’s death during the contract term. The required capital for this risk under SF is calculated as the change in own funds of a permanent increase of mortality rates by 15% for all ages and each policy. For Aegon life and Aegon spaarkas an Internal Model is used to calculate the risk factor.
Longevity risk
Longevity risk is associated with (re)insurance obligations where payments are made until the death of the policyholder and where a decrease in mortality rates results in higher technical provisions. The required capital for this risk under SF is calculated as the change in own funds of a permanent decrease of mortality rates by 20%. For Aegon life and Aegon spaarkas an Internal Model is used to calculate the risk factor.
Disability-morbidity risk
Morbidity or disability risk is associated with all types of insurance compensating or reimbursing losses (e.g. loss of income, adverse changes in the best estimate of the liabilities) caused by changes in the morbidity or disability rates. Solvency II prescribes a 35% increase in disability rates for the first year, 25% for subsequent years, combined with a decrease in recovery rates of 20%. The disability-morbidity risk is calculated on policy level by increasing the experience percentage with 35% for the first year and 25% in the second. For the IBNR reserve the shock is simplified to an average of 30% for the 2-year IBNR cashflow. Because revalidation risk is very small, no shock is modelled for this risk.
Lapse risk
Lapse risk is the risk of losses (or adverse changes in the best estimate of the liabilities) due to an unanticipated (higher or lower) rate of policy lapses, i.e. changes to paid-up status (cessation of premium payment) and surrenders. In general, a lapse shock is only applied if a Solvency II lapse event is actually considered possible under the conditions of the insurance contract. For instance a paid-up policy that cannot be surrendered is not taken into account.
The effect of the lapse risk is equal to the highest result of a permanent increase in lapse rates of 50%, a permanent decrease in lapse rates of 50% or a mass lapse event (an instant lapse event of 40% of all policies). For the mass lapse event, the lapse risk is calculated as the maximum on policy level of a mass surrender or a mass paid-up event.
Expense risk
A calculation is made of the effect on own funds of a permanent increase in costs used for determining the best estimate. It consists of an increase in the costs of 10% and an increase in the cost inflation of 1 percentage point per year. For investment costs only an increase of 10% applies, since it has been substantiated that increases due to inflation including a shock can be absorbed by the Best Estimate itself and asset management for external parties.
Life catastrophe risk
Catastrophe risk arises from extreme events which are not captured in the other Life insurance risks, such as pandemics. The capital requirement for this risk is calculated as a 1.5 per mille increase in mortality rates in the first projected year for (re)insurance obligations where the increase in mortality rates leads to an increase in technical provisions.
Mortgage Loans
Within the Individual life portfolio there is a group of policies directly linked to a mortgage loan ('Spaarhypotheken'). In case the mortgage loan is not provided by a.s.r., but by another party, which is the case for most of these policies, the interest that a.s.r. reimburses to the policyholder is claimed from the party that has provided the mortgage loan. This cashflow of interests from the provider of the mortgage loan to a.s.r. represents an asset. The cashflow and value of this asset depends on the cashflow of the linked savings policy. Therefore, the change in this asset value due to mortality or lapse is taken into account when determining the SCR for Life insurance risks.
For Aegon life and Aegon spaarkas an Internal Model is used to calculate the risk factor.
Employee benefits
a.s.r. has a number of defined benefit plans for own staff in place. These are schemes, under which staff are awarded pension benefits upon retirement, usually dependent on one or more factors such as years of service and salary. The defined benefit obligation is calculated by independent actuaries at each reporting date. Due to the acquisition of Aegon NL the ended defined benefit plan for own staff of Aegon NL was added to the defined benefit obligation per 2023.
Pension obligations are calculated using the projected unit credit method. Inherent to this method is the application of actuarial assumptions to discount rates, mortality rates and consumer price indices.
The assumptions are reviewed and updated at each reporting date based on available (market) data. The discount rate (31 December 2023: 3.42%) is based on the return (zero coupon rate) of high-quality corporate bonds (AA rating) and the cash flow pattern of the pension obligation. For SCR purposes, the IFRS value of the own pension contract is based on the IAS19 valuation methodology. The explanatory guidelines explain that the IAS19 valuation is consistent with Solvency II.
As of 1 January 2021 a defined contribution plan is in place. The accrued pensions (until 1 January 2021) will remain guaranteed at a.s.r. life and are not transferred to the defined contribution plan. The former employees of Aegon NL were added to the defined contribution plan as of 1 October 2023.
Other information
Within a.s.r. life the longevity risk is dominant and arises from group pension business and individual annuities. The longevity risk is partly offset by mortality risk that arises from the funeral portfolio and individual policies with mortality. The other main risks a.s.r. life is exposed to are expense risk and lapse risk.
For the Life portfolio, the provision at year-end (provided figures are without reductions resulting from reinsurance contracts) can be broken down as follows under Solvency II:
| 31 December 2023 | 31 December 2022 |
---|---|---|
Insurance with profit participation | | |
Best estimate | 23,238 | 10,573 |
Risk margin | 950 | 589 |
| | |
Technical provision | 24,188 | 11,162 |
| | |
Other life insurance | | |
Best estimate | 28,426 | 12,859 |
Risk margin | 1,040 | 580 |
| | |
Technical provision | 29,466 | 13,439 |
| | |
Index-linked and unit-linked insurance | | |
Best estimate | 34,677 | 10,173 |
Risk margin | 600 | 62 |
| | |
Technical provision | 35,277 | 10,235 |
| | |
Total | | |
Best estimate | 86,341 | 33,604 |
Risk margin | 2,589 | 1,231 |
| | |
Technical provision | 88,930 | 34,836 |
In 2023 the technical provision increased with € 54,094 million. This was mainly caused by the integration of Aegon.
7.8.2.1.1 Managing Life insurance risk
Life insurance risk is mitigated by pricing, underwriting policies and reinsurance.
Pricing is based on profit capacity calculations. A calculation is made of the price required to cover the insurance liabilities, expenses and risks.
Underwriting policies describe the types of risks and the extent of risk a.s.r. is willing to accept. Policyholders may be subjected to medical screening for both Individual life and Funeral insurance.
Reinsurance
Reinsurance and other risk-mitigating measures are used to reduce the volatility of results or to decrease the possible negative impact on value as an alternative to the capital requirement. Reinsurance arrangements have been set up to mitigate the effects of catastrophes on earnings.
The level of retention in different reinsurance contracts is aligned with the size and the risk profile of the underlying portfolios. This includes taking account of the cost of reinsurance on the one hand, and the risk that is retained on the other.
In order to optimise its balance sheet risks, a.s.r. entered into a reinsurance agreement with Legal and General Re in 2015. The share of Legal and General Re is on behalf of a specific buy-out portfolio. The total share of the reinsurances for a.s.r. amounts to € 120 million per 31 December 2023.
7.8.2.2 Health insurance risk and Non-life insurance risk
7.8.2.2.1 Health insurance risk
The Health insurance portfolio of a.s.r. is diverse. The portfolio can be divided into two main product types:
SLT Health portfolio (Similar to Life Techniques) Income Protection, which can be divided into:
Individual Disability (Zelfstandigen)
Group Disability (WIA)
Premium waiver in case of disability (PVI)
NSLT Health portfolio (Not Similar to Life Techniques), which can be divided into:
Income Protection (Sickness, and Individual and Group Accident)
Medical Expenses (Basic and Supplementary)
The insurance contracts are sold primarily to retail and wholesale clients through intermediaries.
The Health insurance portfolio of a.s.r. contains the following insurance risks:
SLT Health risk
This risk is applicable to the SLT Health portfolio. The calculation is scenario-based, according to the standard formula.
NSLT Health risk
This risk is applicable to the NSLT Health portfolio. The calculation is factor-based. The risk is calculated similarly to the Non-life insurance risk.
Health Catastrophe risk
This risk is applicable to the entire Health portfolio. The calculation is scenario-based.
SLT Health Risk
Mortality risk
Mortality risk is associated with (re)insurance obligations where payments are made upon the death of the policyholder and where an increase in mortality rates results in higher technical provisions. The required capital is calculated as the change in own funds of a permanent 15% increase in mortality rates. The increase in mortality rates is applied to portfolios where payments are contingent on mortality risk. The increase in mortality rates leads to an increase of the own funds. Therefore the mortality risk is zero for the Health portfolio.
Longevity risk
Longevity risk is associated with (re)insurance obligations where payments are made until the death of the policyholder and where a decrease in mortality rates results in higher technical provisions. The required capital is calculated as the change in own funds of a permanent 20% decrease in mortality rates. The decrease in mortality rates is applied to portfolios where payments are contingent on longevity risk.
Disability-morbidity risk
Morbidity or disability risk is the main risk to the SLT Health portfolio. The scenario analysis consists of a 35% increase in disability rates for the first year, 25% for subsequent years, combined with a decrease in revalidation rates of 20%.
Expense risk
A calculation is made of the effect of a permanent increase in costs, which is used for determining the best estimate. The scenario analysis contains an increase in the costs of 10% and an increase in the cost inflation of 1 percentage point per year.
Revision risk
The revision risk is the risk that a higher benefit is caused by either inflation or a revision of the disability percentage. Benefits that are sensitive to inflation and / or an increase in the disability percentage will be increased by 4%.
Lapse risk
Lapse risk is the risk of losses (or adverse changes in the best estimate of the liabilities) due to an unanticipated (higher or lower) rate of policy lapses, terminations, changes to paid-up status (cessation of premium payment) and surrenders. The effect of the lapse risk is equal to the highest result of a permanent 50% increase in lapse rates, a permanent 50% decrease in lapse rates or a mass lapse event (40% mass lapse). For the SLT Health portfolio, the mass lapse event is dominant.
Future management action
According to the insurance conditions, a.s.r. non-life has the ability to adjust the premiums and insurance conditions group wise in the future for the disability portfolio. Therefore, the contract boundary of the disability contracts without an individual risk assessment at acceptance is equal to the contract term. For contracts with an individual risk assessment at acceptance, the contract boundary is equal to the end age, because the contracts will be tacitly renewed until the end age is reached, without repeating the risk assessment. These contracts with an individual risk assessment involve the Individual Self-employed and the Individual Employees portfolio’s. For these portfolio’s, a.s.r. non-life applies a future management action (FMA), as noted in article 23 of the Delegated Acts. The trigger, as defined in the FMA, is hit in the Income Protection Disability-Morbidity Risk (article 156 DA) scenario.
With the inclusion of the Aegon portfolio in the non-life insurance entity, future management actions are applied to both the a.s.r. and Aegon portfolio according to previously used definitions for the specific portfolios.
For a number of Loyalis products within the group disability portfolio, it is determined annually whether the insured amounts are indexed. For the majority of the portfolio, there is a conditional indexation based on a (discretionary) management decision, based among other things on interest result. In a financially unfavourable year, there is the possibility of not paying out indexation, which is a FMA as noted in article 23 of the Delegated Acts.
NSLT Health Risk
NSLT Premium and reserve risk
The premium risk is the risk that the premium is not adequate for the underwritten risk. The premium risk is calculated over the maximum of the expected earned premium of the next year, and the earned premium of the current year. The reserve risk is the risk that the current reserves are insufficient to cover their run-off over a 12 month time horizon.
The NSLT Premium and reserve risk can be split into the following insurance risks:
Medical Expense
A health catastrophe for the NSLT Health portfolio is an unexpected future event with a duration of one year. The risk is determined ultimo year. The amount of catastrophe risk is apparent from the number of insured and parameters for mass accident scenario and pandemic scenario that have been approved by DNB in consultation with Health Insurers Netherlands. Accident concentration is not applicable for NSLT Health. The catastrophe risk has a projection of one year (T) following from the contract boundary of one year in accordance with the Dutch Health Insurance Act. After year T the risk is ‘zero’. Catastrophe risk for a.s.r. health supplementary equals zero because these contracts have a maximum compensation for claims.
Income Protection
This component is calculated for policies for which an increase in mortality rates or morbidity rates or disability rates leads to an increase in the best estimate. There are three scenarios, which are calculated for all NSLT Health and portfolios.
NSLT lapse risk
The basic and additional health insurance are compulsory insurance contracts for one year without intermediate possibility of termination and therefore lapse risk is negligible for the basic health insurance.
Health catastrophe risk
Mass accident scenario
In this scenario, an accident takes place during a major public event. The risk is that 10% of the attendees are killed, 3.5% are permanently disabled, 16.5% are disabled for 12 months and 30% need medical attention.
Accident concentration scenario
In this scenario, an accident takes place on site, with the most of our insured at the same location. The risk is that 10% of those present are killed, 3.5% are permanently disabled, 16.5% are disabled for 12 months and 30% need medical attention.
Pandemic scenario
In this scenario, there is a pandemic, which causes 1% of those affected to be hospitalised and 20% to see a local practitioner.
| 31 December 2023 | 31 December 2022 |
---|---|---|
Health SLT | 1,187 | 964 |
Health Non-SLT | 472 | 404 |
Catastrophe Risk (subtotal) | 88 | 83 |
Diversification (negative) | -239 | -208 |
| | |
Health (Total) | 1,508 | 1,243 |
| | |
Mortality risk | - | - |
Longevity risk | 66 | 52 |
Disability-morbidity risk | 985 | 779 |
Expense risk | 145 | 135 |
Revision risk | 276 | 205 |
Lapse risk | 295 | 270 |
Diversification (negative) | -581 | -478 |
| | |
Health SLT (subtotal) | 1,187 | 964 |
| | |
Medical expenses insurance and proportional reinsurance | 162 | 155 |
Income protection insurance and proportional reinsurance | 370 | 303 |
Diversification (negative) | -60 | -55 |
| | |
Health Non-SLT (subtotal) | 472 | 404 |
| | |
Mass accident risk | 27 | 28 |
Accident concentration risk | 75 | 66 |
Pandemic risk | 37 | 41 |
Diversification (negative) | -51 | -53 |
| | |
Catastrophe risk (subtotal) | 88 | 83 |
The SCR for the Health Non-SLT risk differs from the sum of the amounts reported in the OTSO QRTs. This difference is caused due to a diversification benefit on group level.
For the SLT Health portfolio, the provision at year-end can be broken down as follows under Solvency II.
| 31 December 2023 | 31 December 2022 |
---|---|---|
Best estimate | 4,657 | 3,389 |
Risk margin | 584 | 371 |
| | |
Technical provision | 5,241 | 3,760 |
For the NSLT Health portfolio, the provision at year-end can be broken down as follows under Solvency II.
| 31 December 2023 | 31 December 2022 |
---|---|---|
Best estimate | 612 | 526 |
Risk margin | 61 | 54 |
| | |
Technical provision | 673 | 579 |
7.8.2.2.2 Non-life insurance risk
Non-life Insurance risk can be broken down into:
Premium and reserve risk
Non-life catastrophe risk
Lapse risk
Premium- and reserve risk
The premium- and reserve risk is derived at the level of a legal entity based on the standard model. The premium- and reserve risk is the risk that the premium respectively the reserve is not adequate for the underwritten risk. The reserve risk is associated with historical years, and the premium risk is associated with the future year(s). The premium risk is calculated over the maximum of the expected earned premium for the next year and the earned premium for the current year. For the calculation of the premium- and reserve risk, several input data and parameters are necessary, as described in the standard model. The geographical spread, when a (re)insurer underwrites products in different countries, is not relevant for a.s.r. non-life as there is no material exposure outside the Netherlands.
Non-life Catastrophe Risk Module
Catastrophe risk is defined as the risk of loss or adverse change in the value of insurance liabilities, resulting from significant uncertainty of pricing and provisioning assumptions related to extreme or exceptional events. The Non-life SCR Catastrophic Risk Module used, consists of natural catastrophe risk (Windstorm and Hail), man-made catastrophe risk (Fire, Motor and Liability) and other Non-life catastrophe risk. The Non-life Catastrophe Risk Module is derived at the level of a legal entity based on the standard model.
Lapse risk
The lapse risk is the loss in basic own funds caused by the discontinuance of 40% of the policies for which discontinuation would result in an increase of technical provisions (without the risk margin). The calculation is based on the type of discontinuance which most negatively affects the basic own funds, which is for Non-life immediately termination of the policy.
Below table summarises the required capital for abovementioned Non-life insurance risks based on the standard model.
| 31 December 2023 | 31 December 2022 |
---|---|---|
Premium and reserve risk | 640 | 548 |
Lapse risk | 51 | 52 |
Catastrophe risk | 175 | 159 |
Diversification (negative) | -160 | -149 |
| | |
Non-life insurance risk | 706 | 609 |
| | |
Natural catastrophe risk | 148 | 132 |
Man-made catastrophe risk | 91 | 86 |
Other non-life catastrophe risk | 20 | 20 |
Diversification (negative) | -85 | -79 |
| | |
Catastrophe risk (subtotal) | 175 | 159 |
For the Non-life portfolio, the provision at year-end can be broken down as follows under Solvency II:
| 31 December 2023 | 31 December 2022 |
---|---|---|
Best estimate | 1,802 | 1,479 |
Risk margin | 105 | 88 |
| | |
Technical provision | 1,907 | 1,567 |
7.8.2.2.3 Managing Health and Non-life insurance risk
Health and Non-life insurance risk is managed by monitoring claims frequency, the size of claims, inflation, handling time, benefit and claims handling costs, and biometrical risks (disability, recovery, illness, death). Concentration risk also qualifies as an insurance risk.
In recent years, measures have been taken to improve profitability and reduce risk. Examples are: premium increases, stricter acceptance criteria, shorter claims filing terms and making use of the claims reassessment arrangement between the Dutch Association of insurers and social security institute UWV. Effects are being monitored closely and assessed to be effective.
Claims frequency, size of claim and inflation
To mitigate the risk of claims, a.s.r. bases its underwriting policy on claims history and risk models. The policy is applied to each client segment and to each type of activity. In order to limit claims and / or ensure that prices are adjusted correctly, the acceptance policy is continually refined using a number of indicators and statistical analyses. The product lines also use knowledge or expectations with respect to future trends to estimate the frequency, size and inflation of claims. The risk of unexpected major damage claims is contained by policy limits, the concentration of risk management and specific risk transfer contracts (e.g. reinsurance).
Handling time
The time required for handling and settling claims is an important factor. The settlement of claims that have a long handling time, such as liability claims, can take many years. Analyses are performed regularly and based on a.s.r.’s experience in similar cases, historical trends – such as the pattern of liabilities – increases in risk exposure, payment of damages, the scale of current and not yet settled damage claims, court rulings and economic conditions.
Benefit and claims handling costs
Taking estimated future inflation into account, benefit and claims handling costs are managed based on regular reviews and related actions.
Disability risk
Disability risk is controlled by means of regular evaluation of historical claims patterns, expected future developments and price adjustments. Disability risk is mitigated by a.s.r. through underwriting criteria and a proactive reintegration policy. a.s.r. non-life ended the mitigation of its disability risk through reinsurance in 2023. Only for Aegon there is a limited amount of active reinsurance.
Concentration risk
Geographically, the risk exposure of a.s.r. on its health and Non-life portfolio is almost entirely concentrated in the Netherlands. Concentration of insurance risks is particularly prevalent in the fire risk portfolio (i.e. home and content, with storm and flood risk forming the most important factor). Storm and flood risk is managed by means of suitable reinsurance (see also ‘Reinsurance’).
There is also a concentration of risk in group disability schemes. Group disability contracts are underwritten within the scope of disability cover for employees in the Netherlands (WIA).
Reinsurance
When deemed effective in terms of capital relief versus costs incurred, a.s.r. enters into reinsurance agreements to mitigate Non-life insurance risks. Reinsurance can be taken out for each separate claim (per risk), for the accumulation of claims due to natural disasters or to human actions (per event), or for both these risks.
The level of retention in the various reinsurance contracts is aligned with the size and the risk profile of the underlying portfolios, taking into account of the cost of reinsurance on the one hand, and the risk that is retained on the other.